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1. Introduction 
Leprosy is a chronic infectious disease of varying severity caused by Mycobacterium leprae 
(M. leprae) a slowly multiplying pathogen. It is primarily a surface disease with lesions 
mainly involving the skin and peripheral nerves. Rarely visceral organs like liver, 
lymphnodes, bone marrow, eyes, bones and testes may be involved. Despite the prevalence 
rate of leprosy having steadily fallen throughout the world, it continues to be a cause of 
significant public health problem and morbidity in endemic regions. The disease is endemic 
in many tropical and subtropical countries but is declining in incidence. Globally, 211903 
new leprosy cases were detected in 2010 (WHO, 2010). The most affected countries are India 
and Brazil with some countries in Sub Saharan Africa and Southeast Asia (Noordeen, 1995). 
The mode of transmission is still unknown but it is believed to be through inhalation of 
bacilli that are excreted from the nasal passages of the multibacillary patient. Direct person-
to-person transmission through skin contact occurs rarely though there have been isolated 
reports of its transmission from hypodermic needles during skin tattooing or by physical 
trauma to skin. 
2. Clinical and immunopathologic spectrum of leprosy 
The sequence of disease pathogenesis in leprosy is complex and depends on the host 
immunological responses. M. leprae is non-toxic and the clinicopathologic manifestations are 
the result of this host-parasite interaction. (Ridley & Jopling, 1966; Ridley,1974). Leprosy is the 
classical example of the disease with an immunopathologic spectrum wherein the host 
immune reaction to the infective agent ranges from none to marked with a consequent range 
of clinicopathologic manifestations. Tuberculoid leprosy (TT) shows a high cellular response 
characterized by T-cell and macrophage activation and very few bacilli in the tissues. 
Lepromatous leprosy (LL) on the opposite pole shows an absent cellular immune response to 
M. leprae antigens with no macrophage activation and abundant bacilli in the tissues. The 
immunopathologic spectrum is a dynamic continuum in which the patients move in either 
direction according to the host immune response and treatment. The standard delineation 
follows the classification of Ridley and Jopling with categories defined along this spectrum by 
a combination of clinical, microbiological and histopathological indices: TT (tuberculoid), BT 
(borderline tuberculoid), BB (midborderline), BL (borderline lepromatous) and LL 
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(lepromatous leprosy). The TT and LL group of patients are stable, the former often self-
healing and the latter remaining heavily infected unless given chemotherapy. The central point 
of the spectrum BB is most unstable with patients quickly downgrading to LL if not treated. 
Apart from these there are some patients who are labeled as ‘indeterminate’ leprosy and these 
are the patients with the earliest identifiable skin lesions that cannot be categorized definitely 
in the immunopathologic spectrum (Table1). 
 
 
Table 1. Classical features of the leprosy spectrum 
3. Leprosy reactions 
Leprosy reactions are periodic episodes of acute inflammation caused by immune responses 
to M. leprae or its antigens superimposed on the chronic course of the disease. There are two 
main types of leprosy reactions depending on the underlying immunological mechanisms. 
3.1 Reversal reaction 
It is also referred to as type 1 reaction or upgrading reaction and occurs either spontaneously 
or after a course of chemotherapy and is due to increase in the delayed hypersensitivity 
reaction. There is influx of lymphocytes that are mainly of CD4+ subtype, especially of the Th1 
class (Yamamura et al., 1991; Sreenivasan et al, 1998). During type1 reaction, increases in gene 
expression of several proinflammatory cytokines have been documented (Scollard et al, 2006). 
These episodes show cardinal features of inflammation such as erythema, edema, local 
warmth and tenderness over the skin lesions. The most important effect of a reversal reaction 
is not the skin but the peripheral nerves which show acute neuritis due to infiltration of 
lymphocytes and increased intraneural pressure that may result in nerve abscess, necrosis and 
loss of nerve function. 
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3.2 Erythema nodosum leprosum (ENL) 
It is also known as type 2 reaction and occurs as an acute episode. LL leprosy patients with 
high bacillary index are more prone to develop ENL as compared to BL leprosy (Pfaltzgraaf et 
al, 1994). Based primarily on histopathological evidence, it had been proposed that ENL 
represents an Arthus-like phenomenon mediated by immune complexes (Wemambu et al, 
1969). Immunoglobulins and complement deposits have been demonstrated in the skin lesions 
consistent with this hypothesis. However, neither circulating nor fixed immune complexes 
have been reproducibly demonstrated in ENL lesions. Other studies have demonstrated 
evidence of increases in circulating IFN-γ, TNF-α and IL12 and chemokines associated with 
chemotaxis of neutrophils. Increases in m RNA expression of these cytokines have also been 
observed in biopsies of skin lesions suggesting that cellular immune activation occurs locally 
(Sreenivasan et al, 1998; Scollard et al, 2006). Both immune complex deposition and enhanced 
T-cell reactivity have been demonstrated in peripheral blood and skin lesions. Clinically the 
skin shows redness, edema, tender plaques and nodules and rarely vesicle formation and 
ulceration. The eruptions are widespread and associated with constitutional symptoms like 
fever, arthralgia and involvement of other visceral organs.  
3.3 Lucio phenomenon 
It occurs in diffuse lepromatous (Lucio) leprosy patients who have either received no 
treatment or incomplete treatment and have been predominantly observed in Mexican and 
South American populations. In contrast to ENL, fever, tenderness and leucocytosis are 
absent. The lesions present as hemorrhagic, sharply marginated irregular crusted plaques 
that have tendency to ulcerate. 
4. Skin biopsy technique 
Skin biopsy is a key clinical procedure that is routinely required for the histopathological 
diagnosis of leprosy and is of paramount importance for correct histopathological 
classification, bacillary index, and follow-up of treatment response and disease activity. It is 
also useful for differentiating a relapse from a reversal reaction and to categorize reactions 
into type 1 or type2. 
4.1 Principles of skin biopsy  
Before planning a skin biopsy the patients should be informed about the procedure and its 
side effects. In some countries it is mandatory to obtain a signed consent form. If the patient 
is illiterate as is common in many endemic countries, care should be taken to explain the 
procedure verbally and obtain if required a thumbprint on the consent form. Institutional 
ethical committee’s permission is not mandatory for diagnostic biopsies, however whenever 
the skin biopsy forms part of research project, it is essential to obtain a prior approval from 
such a committee. Any history of a bleeding disorder or intake of drugs that may interfere 
with hemostasis should be investigated prior to taking the biopsy. 
4.2 Site selection 
Deciding the site from where the biopsy will be taken is crucial. Generally the lesions with 
more advanced inflammatory changes should be chosen. The area from where the biopsy is 
to be taken should be marked with a skin marker by the physician (Figure 1A).The 
manifestations of leprosy lesions may vary but generally the site should be active and 
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representative. If a small hypopigmented patch suspected to be indeterminate leprosy is 
seen, the biopsy should be taken from the center of the lesion where the disease is active. If 
the lesion is an annular macule then the active spreading edge should be the ideal site of 
biopsy. If the patient has multiple lesions of different morphology, then more than one 
biopsy should generally be taken. Even though punch biopsies cause very little scarring care 
should be taken to avoid wherever possible the cosmetic sites such as face and areas with 
poor healing characteristics (Alguire & Mathes, 1998).The depth of the biopsy in leprosy 
should include full depth of the dermis and should extend till the subcutis so as to involve 
the deeper nerve bundles as well as subcutaneous fat. 
4.3 Site preparation 
Any common skin antiseptic such as isopropyl alcohol, povidone-iodine solution or 
chlorohexidine gluconate can be used to prepare the biopsy site (Pariser, 1989). The most 
commonly used anesthetic agent is 2% lignocaine 1ml of which is injected intradermally in 
stages while the needle is being inserted in the skin (Figure 1B). Since lignocaine is a 
vasodilator, small quantity of epinephrine may be added to decrease bleeding and prolong 
anesthesia. For small lesions the anesthetic can be directly injected into or adjacent to the 
lesion. For larger lesions a field block is recommended by placing a ring of anesthesia 
around the intended surgical site (Harrison, 1980). 
4.4 Type of skin biopsy 
Skin biopsy is a relatively simple procedure that is performed as an outpatient procedure 
and is essentially of three types 
a. Incisional biopsy: is about 12 mm long is in practice, ideal for detection of early lesions. 
They are reserved for lesions that cannot be removed with a punch owing to their size, 
depth or location. These need sufficient expertise and invariably require sutures. They 
are usually reserved for deep inflammatory lesions or lesions involving the panniculus, 
ex. ENL. After taking the biopsy, the skin tissue is immediately placed in appropriate 
preservative depending upon type of investigation to be carried out. 
b. Punch biopsy:  is the most commonly performed skin biopsy and is the biopsy of choice 
for diagnostic purpose. Biopsy punch is a metal cylinder of variable diameter with a 
sharp cutting edge and usually attached to a plastic handle (Figure 1C). The diameter 
ranges from 3-10 mm. Ideally, 4-6mm punches are adequate but 3 mm is the minimum 
tissue that is considered sufficient for giving a consistently accurate histological 
diagnosis (Todd, et al., 1996). Biopsy punches blunt easily therefore disposable punches 
are recommended. Punch biopsies heal by secondary intention though lesions greater 
than 3mm can sometimes give unacceptable scarring and require 1-2 sutures. The skill 
required for such biopsies is easily mastered. In comparison to shave biopsies, punch 
biopsies have a low incidence of bleeding, infection or undesirable scarring (Grekin, 
1989). After selecting the punch size, the skin is stabilized with thumb and index finger 
and slightly stretched perpendicular to the skin tension lines. After placing the punch 
perpendicular to the skin, a firm downward pressure is applied (Figure 1D). When the 
punch touches the subcutaneous fat there is a definite ′give′ indicating that a full 
thickness cut has been made. The punch is withdrawn and the cylindrical piece of tissue 
is gently supported with blunt forceps or a needle tip. The tissue is immediately 
transferred into a fixative solution and a firm pressure is applied on the wound to 
prevent bleeding. 
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c. Shave biopsy: This type of skin sampling is quick, requires little training and sutures for 
closure are not required. They are usually meant for superficial lesions where the 
pathology is confined to epidermis and is not of use in leprosy. 
 
Fig. 1. Selected site for punch biopsy (A), intradermal injection of lignocaine (B), disposable 
needle punch (C), punch held perpendicular to the skin (D) 
4.5 Wound closure  
The simplest technique of wound closure is the simple interrupted suture. Primary closure 
of a punch wound can be accomplished with 1-2 single-layer interrupted sutures. Excisions 
can be closed in 1-2 layers. The qualities that are most important in suture selection are 
flexibility, strength, secured knotting and the infection potential (Moy, 1992). There are two 
broad varieties of sutures absorbable and non-absorbable. Absorbable sutures are made 
from mammalian-derived collagen (gut) and synthetic absorbable material such as 
polyglactic acid (vicryl), polyglycolic acid (dexon), poliglecaprone (monocryl) and 
polydioxanone (PDS). Absorbable sutures have a tensile strength of usually1-2 weeks and 
are usually placed deep in the wound to reduce skin tension for final closure. Non-
absorbable sutures include silk, ethilon (nylon), polypropylene (prolene) and polybutester 
(dacron). Silk and nylon sutures cause considerable tissue inflammation and have now been 
largely replaced by synthetic sutures. The latter have a tensile strength ranging from 3 
months to 2 years. All biopsy wounds can be dressed with a thin film of a broad spectrum 
antibiotic ointment and covered with a non adherent dressing topped with gauze dressing 
and tape (Telfer, 1993). Though skin biopsy is a very safe procedure rarely complications 
like bleeding, hematoma formation, allergic reaction and infection may still occur.  
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4.6 Preservation of the skin biopsy 
As soon as the biopsy is taken it should be transferred to a preservative to prevent tissue 
autolysis and drying artifacts. The ideal fixative for standard paraffin embedded 
histopathological processing is 10% buffered formalin. This fixative is less damaging to the 
granuloma and works well for preserving the morphology of the AFB. Another fixative 
frequently used in the past was Lowy’s fixative or the FMA (formaldehyde, mercuric 
chloride, glacial acetic acid) fixative. If properly undertaken FMA fixative gives good 
cellular details. The biopsy specimen should be completely immersed in the fixative that 
should be at least 10 times the volume of the skin biopsy. The same fixative can be used for 
subsequent staining for histochemical characterization and detection of phenolic glycolipid-
1 (PGL-1) or lipoarabinomannan (Weng, 2000 ; Verhagen, 1999). For electron microscopy the 
fixative of choice is 2% glutaraldehyde. If direct fluorescence is to be done within 24 hours 
then skin biopsy should be thoroughly rinsed with normal saline and preserved at –20 0 C. If 
the biopsy is to be used later, then Michel’s liquid fixative is the recommended transport 
medium. This fixative is a proteolytic enzyme inhibitor and is reconstituted by N-
ethylmalleimide, ammonium sulfate in a citrate buffer and will give the skin biopsy a shelf 
life of 4 weeks to 6 months. For molecular techniques like PCR and in-situ hybridization, 
buffered formalin fixed skin biopsies are considered suitable for PCR as other fixatives may 
inhibit the reaction (Singh et al, 2004). For RNA studies fresh skin biopsies are preserved 
immediately in a RNA stabilizing reagent (RNA later) and preserved at -800 C. 
5. Protocol for staining of Acid Fast Bacilli (AFB) in paraffin embedded tissue 
samples  
5.1 Modified Fite - Faraco stain (Job & Chacko, 1986) 
a. Ziehl-Neelsens Carbol fuschin solution (200ml) are 
Basic fuschin: 2 gm 
Melted-phenol: 10 ml 
Absolute alcohol: 20 ml 
Distilled water: 170 ml 
b. 5% Sulfuric acid (200ml) 
Concentrated sulfuric acid (1.0 N):10ml 
Distilled water: 190 ml 
c. Harris Hematoxylin 
Hematoxylin: 5 gm 
Absolute alcohol: 50 ml 
Potassium alum: 100 gm 
Mercuric oxide: 2.5 gm 
Glacial acetic acid: 25 ml 
Distilled water: 1000 ml 
5.2 Staining procedure 
 Deparaffinize sections in a mixture of xylene and peanut oil (2 parts of xylene,1 part of 
peanut oil), two changes of 6 minute each 
 Drain, wipe off the excess oil and blot with filter paper 
 Wash in running tap water for 4 minutes 
 Stain with Ziehl- Neelsen’s carbol fuschin solution for 30 minutes at room temperature 
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 Wash in tap water for 2 minutes 
 Differentiate sections in  5% sulfuric acid in 25% alcohol for two changes of 2 minutes 
each 
 Wash in running tap water for 5 minutes 
 Drain the excess water, blot dry the sections with a filter paper. Do not dehydrate in 
alcohol. 
 Clear in two changes of xylene and mount 
This staining method has two modifications from the standard Fite-Faraco stain for AFB. 
Firstly, use of alcohol is minimized to prevent excessive decolorization. Secondly, the 
counterstain is hematoxylin instead of methylene blue. AFB show red colour and nuclei 
stain dark blue giving the localization of AFB in relation to the cells.  
6. Fluorescent microscopy in leprosy 
Demonstration of M. leprae during histopathological examination of early lesions is an 
important criterion in the confirmation of leprosy diagnosis. The sensitivity of detection of 
AFB by histological means remains poor because about 1000 bacilli per cubic centimeter of 
tissue must be present in order to detect 1 AFB in a section. To enhance the detection rate it 
is recommended that atleast six sections be examined before declaring them negative. 
Routine acid fast stains are not so sensitive due to the variability in their ability to decolorize 
AFB using acid-alcohol. In the search for more sensitivity, a fluorescent method of staining 
similar to M. tuberculosis has been used and is reportedly 1.5 times more sensitive in 
demonstrating M. leprae than Fite-Faraco stain (Nayak, et al., 2003). Immunofluorescence 
(IF) is also useful in leprosy research where it is a valuable tool in studying localization of 
antigens like immunoglobulins, HLA-DR, cell surface markers and cytokines on frozen skin 
biopsies. IF is a better method for studying double labeling of antigens as compared to 
histochemical staining on formalin fixed paraffin embedded tissue. 
7. Numerical indices in a skin biopsy  
7.1 Granuloma Fraction (GF) 
The fraction of the dermis in a section occupied by a granuloma is observed visually under a 
low-power objective (x 4) and expressed as fractions. For e.g. 1.0 indicates that the whole of 
the dermis is occupied by the granuloma, 0.2 that one-fifth is occupied. The range from 1.0-
0.1 can be estimated quite accurately if the biopsy specimen extends down up to the 
subcutis. Being an arithmetic index, GF is sensitive and can adequately reflect the degree of 
skin infiltration. 
7.2 Bacterial Index (BI) 
BI is the universally accepted method of assessing the load of acid fast bacilli in a leprosy 
patient defined by Ridley (Ridley, 1958).The samples tested can be the skin biopsy or slit 
smears of lesional sites. The latter is obtained as serous fluid by a superficial slit with a 
sterile blade such that no blood contaminates the fluid. The fluid at the tip of the blade is 
smeared on to the glass slides which are then stained with Fite-Faraco stain. 3-6 sites from 
the body are recommended for testing. Slit smear examination is undertaken periodically 
for assessing improvement with drug therapy and is less invasive than the skin biopsy 
and is useful in the field sites where facilities for histopathology may not be available.  
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The bacterial load in skin biopy or slit skin smears is graded using an oil immersion 
objective as: 
 
0:  No bacilli found in 100 microscopic fields  
1+: 1-10  bacilli in 100 microscopic fields 
2+: 1-10  bacilli in 10 microscopic fields 
3+: 1-10  in one microscopic field 
4+: 10-100  in one microscopic field 
5+: 100-1000  bacilli in one microscopic field 
6+: Over 1000  bacilli and globi in one microscopic field 
The BI is calculated as mean BI of the sites tested. 
7.3 Histopathological Index (HI) 
HI is the logarithmic index of bacilli in a biopsy and makes use of the GF and BI to assess the 
number of bacilli in the tissue section. The actual number of bacilli in the volume of given 
tissue can be calculated from the HI 
8. Histopathology of leprosy 
Taking a skin biopsy from the advancing cutaneous lesion in a patient suffering from 
leprosy is the single most informative procedure for diagnosis of leprosy spectrum and 
because of its ability to provide insight into the underlying disease process. The skin biopsy 
captures the pathology of the lesion at a given point and is a very useful resource that can be 
used for further investigation of the patient (Figure 2A-F). Standard histopathological 
examination of the formalin-fixed paraffin embedded skin tissue can provide information 
regarding cellular morphology, presence of AFB and can be further enhanced by techniques 
like imunohistochemistry, immunoelectron microscopy and molecular studies. Pure neuritic 
leprosy is another variant which shows typical tuberculoid or borderline features in nerves. 
Nerve biopsy is required for diagnosis in such cases but if the subject also shows skin 
lesions then nerve biopsy is not considered to be essential. 
There are several useful applications of histopathological examination of the skin biopsy 
from a leprosy patient namely: 
a. to confirm the diagnosis of leprosy 
b. to accurately classify  the lesion in the leprosy spectrum  
c. for identification of the bacillary load in the tissue 
d. in assessment of disease activity and response to treatment 
e. for the diagnosis of a leprosy reaction 
8.1 Indeterminate leprosy 
Indeterminate leprosy is the earliest detectable skin lesion comprising one or few 
hypopigmented macules with no clear sensory changes. The skin biopsy may show mild 
accumulation of lymphocytes and macrophages and an occasional AFB either in the non-
inflammed nerve, erector pili or in the subepidermal zone in the very early stages. It may 
show neuritis evidenced by Schwann cell proliferation and infiltration of the nerve fibres 
with lymphocytes. Nerve infiltration is the most significant feature of leprosy when the rest 
of the skin shows non specific changes. Moreover, the histological changes are known to 
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precede the clinical manifestations by atleast 3 months (Ridley, 1978). Most indeterminate 
leprosy cases are known to heal spontaneously (Crawford, et al., 1977) but since it is not 
possible to predict which indeterminate cases will evolve into full blown leprosy, it is 
considered ethical to treat all the patients.  
8.2 Tuberculoid Leprosy (TT) 
Primary polar tuberculoid leprosy has large and compact epitheloid cell granulomas along 
the neurovascular bundles with lymphocytes. Langhans giant cells are typically scanty or 
absent and AFB are rare to find. Epitheloid cell granuolmas always erode into the basal 
layer of the epidermis. The dermal nerves may be either obiliterated and completely effaced 
or eroded by the dense lymphocyte cuff.  
8.3 Borderline Tuberculoid leprosy (BT) 
The epitheloid granulomas of BT do not invade into the epidermis and have less 
lymphocytes in comparison to TT. The granulomas are arranged in a curvilinear pattern 
along the neurovascular bundle. Nerve erosion by the granuloma is typical and AFB are 
scanty (ranging from BI 0-2) and are more readily detected in the Schawann cells of the 
nerves. In addition to nerves, the granuloma can also involve the sweat glands and the 
erector pili muscle. 
8.4 Midborderlne leprosy (BB) 
The histopathology in BB shows almost equal admixture of epitheloid cells and 
macrophages without forming a distinct granuloma. The lymphocytes are scant and 
scattered and multinucleate giant cells are absent, a feature that helps it to be distinguished 
from BT. AFB may be frequent (ranging from BI 2-4) 
8.5 Borderline Lepromatous leprosy (BL) 
The predominant cells in the granulomas are macrophages with occasional epitheloid cells 
arranged in patches. Lymphocytes are sparse, AFB are abundant (ranging from BI 3-5) but 
usually not present as globi. Perineural fibroblast proliferation forming an ‘onion skin’ in 
cross section is a typical feature. Early evidence of foamy change may be detectable. 
8.6 Lepromatous Leprosy (LL) 
The typical features consist of a flattened epidermis separated from the dermal infiltrate by 
a dense zone of normal collagen. The macrophage granuloma of LL is large and expansile 
consisting of sheets of foam cells with rare presence of lymphocytes. The foam cells harbor 
abundant AFB (ranging from BI 4-6). The solid bacilli are stacked like cigars and appear as 
globi. Such appearance is the rule rather than an exception. In contrast to tuberculoid 
leprosy, the nerves in the skin of LL patients may contain considerable AFB, however, the 
morphological features of the nerve is fairly well preserved in the earlier phase of the 
disease before eventually becoming fibrotic. 
8.7 Lucio leprosy 
The histopathology of this Mexican variant is similar to LL but with a characteristic heavy 
bacillation of the small blood vessels of the skin leading to thrombosis of vessels and 
ischemia and ulceration called as the ‘lucio’ phenomenon. 
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8.8 Histiod leprosy 
This is another variant of LL, which shows the highest load (BI 6) of solid staining AFB 
arranged in clumps and sheaves. The macrophage reaction is unusual in the sense that the 
macrophages become spindle shaped and oriented in a storiform pattern reminiscent of a 
fibrohistiocytoma. 
 
 
Fig. 2. Photomicrograph showing  compact epithelioid granulomas in BT(A), multinucleate 
Langhans giant cells (B), epidermal erosion in leprosy reversal reaction (C), foamy 
macrophage granuloma of LL (D), ENL showing infiltration in subcutis along with 
neutrophils (E), Fite stain showing numerous globi (F) and AFB (inset) (magnification 40X 
except for inset which is 100X oil immersion) 
9. Histopathological differential diagnosis  
Tuberculoid leprosy needs to be differentiated from other granulomatous dermatitides. 
Cutaneous tuberculosis is the most important differential diagnosis which has to be excluded. 
The epidermis in tuberculoid leprosy is usually flat and not hyperplastic as in tuberculosis. 
The arrangement of the granulomas in leprosy is along the neurovascular bundles giving an 
oblong pattern to the granuloma unlike tuberculosis where there is intense and sometimes 
lichenoid pattern of the chronic granulomatous infiltrate. The dermal nerve twigs are spared 
by the infiltrate in tuberculosis. The presence of granuloma or AFB in the nerve is a conclusive 
proof of leprosy. Cutaneous sarcoidosis may sometimes be confused with tuberculoid leprosy 
as fibrinoid necrosis may be found in both these entities. The granuloma of sarcoidosis show 
paucity of lymphocytes and are more confluent and show fibrosis around the granuloma. 
Other granulomatous lesions like leishmaniasis or granulomatous post kala azar dermal 
leishmaniasis also need to be excluded by demonstration of Leishman-Donovan bodies and 
frequent presence of plasma cells. Borderline lepromatous and pure lepromatous leprosy may 
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be confused with histocyte-rich lesions like xanthomas, however demonstration of AFB in 
these lesions usually solves the diagnostic dilemma. 
10. Histopathology of leprosy reactions 
Histopathological examination of a skin biopsy of reversal reaction will show dermal and 
intragranuloma edema. The granulomas become more epitheloid, show infiltration of 
lymphocytes within and around them and the Langhans giant cells become increased in 
number and bigger in size and may also show bizarre shapes. The granulomas also erode 
into the epidermis representing the upgrading reaction. In addition caseous necrosis may be 
evident in the nerves. At the molecular level, the events in type 1 reaction are responses to 
an array of cytokines secreted by the lymphocytes and macrophages. The skin and nerves 
are infiltrated by interferon-γ and tumor necrosis factor-α secreting CD4+ lymphocytes and 
are responsible for the inflammation and tissue damage. 
On histopathology, a type 2 reaction is characterized by varying degree of polymorphonuclear 
infiltration superimposed on already existing lepromatous granuloma. The influx of 
neutrophils can be intense so as to form neutrophilic microabscess. Edema is frequently 
present in the dermis. Deposition of immune complexes in the small cutaneous capillaries, 
arterioles and venules result in necrotizing vasculitis. The downgrading reaction is reflected by 
deeper infiltration of foamy histiocytes into the subcutaneous fat. The AFB are fragmented and 
granular. Superficial ulceration, bulla formation and necrosis may sometimes supervene. 
11. Skin biopsy in relapse  
Relapse in paucibacillary (PB) leprosy may be defined as appearance of a new skin lesion or 
increase in the size of a pre-existing skin lesion provided there is a strong clinical and/or 
histopathological evidence of leprosy in such a lesion (Boeriggter, 1991). The difficulty in 
relapse in PB is to differentiate relapse from a type 1 reaction or drug resisitance. A true 
relapse can be detected histopathologically only after recording complete histological 
resolution of the earlier lesion in a previous biopsy. A relapse indicates that the AFB have 
survived despite antileprosy therapy and have multiplied and released antigens to produce 
fresh granulomas at the site of original lesion and show solid staining viable AFB. 
Alternatively, a fresh infection or reinfection may have occurred on reexposure. The cause of 
relapse may be irregular, inadequate therapy, presence of high initial BI, presence of 
‘persistors’ bacilli that had remained dormant. Relapse in multibacillary (MB) leprosy are 
characterized in the early stage of relapse by  emergence of foci of spindle shaped 
macrophages with granular, eosinophilic cytoplasm along with small foci of persisting 
foamy histiocytes and solid staining AFB in these patients who have not completely become 
smear negative. In late stage of relapse perineural thickening, fibrosis along with Schwann 
cell and endothelial cells packed with solid AFB are detectable.  
A relapse can be differentiated from a reversal reaction by the fact that reversal reaction 
usually occurs within 6 months of release from treatment while relapse occurs after a year of 
release. The reversal reaction additionally shows erythema, edema, neuritis and fewer new 
lesions unlike relapse. Reactions respond well to steroids and show complete subsidence of 
lesions in 2-4 weeks whereas the relapse will show only partial or no response. Owing to 
chronic course and long duration of treatment, drug resistance is an emerging problem in 
leprosy. Drug resistance can be primary or secondary due to mutant bacilli surviving in a 
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setting of monotherapy as in dapsone resistance or irregular therapy as seen in rifampicin 
resistance. While there is appearance of new lesions and patient downgrades in drug 
resistance, in relapse there is reappearance over the old lesions but the patient rarely 
downgrades. 
12. Use of  molecular tools in leprosy 
Definitive identification of M. leprae is somewhat problematic since the organism is not 
cultivable. This problem is further confounded by increased prevalence of other 
mycobacterial infections of skin. Molecular tests like real time PCR are being used for the 
rapid detection and quantification of bacterial DNA content from the clinical biopsy samples 
in which AFB were not detectable by conventional histopathological staining (Martinez et 
al., 2006). Molecular methods can help in rapid direct identification of drug resistance. 
Mutations in the M. leprae genome that are associated with resistance to several drugs have 
been identified and DNA analysis to detect these mutations has largely replaced the mouse 
footpad technique. Mutations in targeted genes can be identified by molecular approaches 
such as probe assays and sequencing and the magnitude of drug resistant mutants can be 
assessed from the biopsy samples (Honore & Cole, 2001)). Decrease in PCR signals have 
been shown to correlate with effect of therapy and cases showing persistence of signals for 
longer periods have been shown to correlate with higher relapses. (Wood & Cole, 1989; 
Gupta et al, 2001; Singh et al,1999). These molecular tools therefore can be useful adjuncts to 
clinical and histopathologic diagnosis of leprosy. 
Molecular tools are also being increasingly used for research. Pathogenesis of leprosy is 
being explored by studying the expression of cell markers, cytokines and growth factors.  
M. leprae being noncultivable by conventional means constrained information on its 
metabolism and strain variations. Subsequent to the sequencing of its genome from an 
Indian strain, it has become possible to understand its genetic makeup. In addition, it has 
become possible to characterize strains of M. leprae using short tandem repeats of 
nucleotides in the genome sequence of the bacillus. Global studies are underway to study 
the distribution of strains as well as pathogen transmission by DNA based signatures of the 
bacilli. Since M. leprae is noncultivable, such strains are obtained from skin biopsies. DNA is 
extracted and amplified by PCR and probed with appropriate probes. Using archival 
material it has been possible to investigate the evolution of M. leprae as well as its origin in 
man in Africa and its subsequent spread to other parts of the world along with its human 
host (Monot et al, 2009; Singh & Cole, 2011). Recent evidence indicates that the organism 
from disseminated lepromatous leprosy endemic to Mexico and Latin America has different 
molecular signatures to M. leprae and has thus been given the new nomenclature of M. 
lepromatosis (Han et al, 2009). 
13. Conclusion 
Skin biopsy is integral to the understanding of leprosy, its causative organism and for 
monitoring its relapse and drug resistance. Diagnosis of leprosy has been based on classical 
cardinal signs, characteristic histopathological findings and demonstration of acid-fast 
bacilli both from the skin smears and skin biopsies of these lesions. The current primary goal 
is early diagnosis of this disease in order to interrupt the transmission by early treatment. 
Histopatholgical examination of the lesional skin is still the gold standard in confirmation of 
its diagnosis and its classification based on the immunopatholgic status. As new serological 
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and molecular tests become available for the early diagnosis of leprosy, its reactions and 
resistance to drugs, skin biopsies will continue to compliment these emerging tools for 
providing more insights into the pathology of this fascinating disease.  
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